Markets are Closed
Company Logo
ANGO
AngioDynamics Inc.

Open

20.19

Previous Open

20.30

High

20.71

Previous High

20.73

Low

20.19

Previous Low

19.77

Close

Previous Close

20.15

Volume

196,373

Previous Volume

274,707

Company Profile

Description

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Exchange

Nasdaq Global Select

List Date

May 27, 2004

CEO

James C. Clemmer

Employees

1,145

Financials

Revenue

270.63M

Earnings

62.88M
392M
293M
194M
94M
-4M
2015
2016
2017
2018

Splits

No splits to date

Dividends

No dividends paid to date

Related News

News post image: AngioDynamics (ANGO) Upgraded to Buy: Here's What You Should Know
AngioDynamics (ANGO) Upgraded to Buy: Here's What You Should Know
Mar 25, 2020 @ 16:00
AngioDynamics (ANGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy)....
finance yahoo
News post image: AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
Mar 10, 2020 @ 20:01
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2020 before the market open on Tuesday, April...
finance yahoo
News post image: AngioDynamics to Present at Two Investor Conferences in March
AngioDynamics to Present at Two Investor Conferences in March
Feb 27, 2020 @ 21:01
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present at the following two investor conferences in March:...
finance yahoo
News post image: AngioDynamics investing $7 million in Glens Falls and Queensbury
AngioDynamics investing $7 million in Glens Falls and Queensbury
Feb 26, 2020 @ 11:00
"If you are interested in three quarters or four quarters, we might not be your company to invest in," CEO Jim Clemmer said. "If you are interested in three or four or five years, that's what we are building here."...
finance yahoo
News post image: Calculating The Intrinsic Value Of AngioDynamics, Inc. (NASDAQ:ANGO)
Calculating The Intrinsic Value Of AngioDynamics, Inc. (NASDAQ:ANGO)
Feb 09, 2020 @ 14:34
Today we will run through one way of estimating the intrinsic value of AngioDynamics, Inc. (NASDAQ:ANGO) by estimating......
finance yahoo
News post image: AngioDynamics (ANGO) Down 10.4% Since Last Earnings Report: Can It Rebound?
AngioDynamics (ANGO) Down 10.4% Since Last Earnings Report: Can It Rebound?
Feb 06, 2020 @ 16:30
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
finance yahoo
News post image: AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
Feb 06, 2020 @ 13:00
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive Vice President and Chief Financial Officer, effective...
finance yahoo
News post image: AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
Jan 16, 2020 @ 16:00
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD-05), a pilot study to evaluate the...
finance yahoo
News post image: Edited Transcript of ANGO earnings conference call or presentation 7-Jan-20 1:00pm GMT
Edited Transcript of ANGO earnings conference call or presentation 7-Jan-20 1:00pm GMT
Jan 09, 2020 @ 23:27
Q2 2020 AngioDynamics Inc Earnings Call...
finance yahoo
News post image: AngioDynamics' latest acquisition will boost $95 million business line
AngioDynamics' latest acquisition will boost $95 million business line
Jan 08, 2020 @ 11:00
It is the latest in a string of acquisitions for AngioDynamics as chief exec Jim Clemmer refocuses the medical device maker by "carving out significant space in larger and faster growing markets."...
finance yahoo
All data provided on Polygon is provided for informational purposes only, and is not intended for trading or investing purposes.
Copyright © 2021, Polygon.io, Inc. All Rights Reserved.
TradingView Lightweight Chart: Copyright (с) 2020 TradingView, Inc. https://www.tradingview.com/